The clinical research of effect of YiGuanJian Decoction on liver cirrhosis post HBV (Liver-Kidney Yin deficiency syndrome)
- Conditions
- liver cirrhosis post HBV
- Registration Number
- ITMCTR2000003798
- Lead Sponsor
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Ages 18 to 65, regardless of gender;
(2) It conforms to the western medicine diagnostic criteria of liver cirrhosis post HBV, and the TCM syndrome differentiation criteria of liver-kidney Yin deficiency syndrome, and the CTP score is 7-9 points (Grade B);
(3) Patients who are taking or preparing to take Entecavir;
(4) The person or his guardian agrees to participate in the randomized controlled trial and signs the informed consent.
(1) Liver failure;
(2) Hepatitis with other hepatitis virus infection, fatty liver, long-term alcohol consumption or other chronic severe hepatitis;
(3) Women who are pregnant or preparing for pregnancy, or women who are breastfeeding;
(4) Severe underlying diseases: severe COPD, severe renal insufficiency, chronic congestive heart failure, etc.
(5) Patients with immunodeficiency, such as malignant tumor, organ transplantation and taking immunosuppressive drugs or glucocorticoids within the last 3 months;
(6) Patients participating in other clinical trials;
(7) Other conditions that the researcher believes are not suitable for inclusion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method